| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Evommune, Inc. | Director, 10%+ Owner | Common Stock | 5,288,313 | $147,438,166 | $27.88 | 17 Feb 2026 | Indirect |
| Evommune, Inc. | Director, 10%+ Owner | Series A Preferred Stock | 0 | 07 Nov 2025 | Direct | ||
| Evommune, Inc. | Director, 10%+ Owner | Series B Preferred Stock | 0 | 07 Nov 2025 | Direct | ||
| Evommune, Inc. | Director, 10%+ Owner | Series C Preferred Stock | 0 | 07 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EVMN | Evommune, Inc. | 17 Feb 2026 | 1 | +$9,999,998 | 4 | Director, 10%+ Owner | 19 Feb 2026, 16:30 |
| /report/000187626425000006-lsp-7-cooperative-ua-2025-11-07 | Evommune, Inc. | 07 Nov 2025 | 5 | +$25,000,000 | 4 | 10%+ Owner | 12 Nov 2025, 16:25 |
| /report/000187626425000004-lsp-7-cooperative-ua-2025-11-05 | Evommune, Inc. | 05 Nov 2025 | 0 | $0 | 3 | 10%+ Owner | 05 Nov 2025, 20:12 |